Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06308952Phase 4Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

Role: collaborator

NCT06898216Not ApplicableRecruiting

Steerable vs Conventional FANS for <2cm Lower Pole Stone Treatment: SCULPT Trial

Role: collaborator

NCT03700801Phase 4Completed

Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy

Role: collaborator

NCT03474172Not ApplicableCompleted

Development and Validation of a Cloak Shape Device for Sham Pediatric Tuina

Role: collaborator

NCT03005821Not ApplicableCompleted

Chinese Pediatric Massage on Children With Acute Diarrhea: a Randomized Sham Massage Controlled Trial

Role: collaborator

NCT03909555Unknown

Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 Diabetes

Role: collaborator

NCT03701217Phase 2Unknown

Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML

Role: collaborator

NCT01402232Unknown

REduction of rIsk for Contrast Induced Nephropathy

Role: collaborator

All 8 trials loaded